P3 Health Partners Q1 2024 GAAP EPS $(0.16) Misses $(0.11) Estimate, Sales $388.488M Beat $352.466M Estimate
Portfolio Pulse from Benzinga Newsdesk
P3 Health Partners (NASDAQ:PIII) reported Q1 2024 earnings with a GAAP EPS of $(0.16), missing the $(0.11) estimate by 45.45%, but saw a 27.27% improvement from last year's $(0.22) per share. Sales reached $388.488M, exceeding the $352.466M estimate by 10.22% and marking a 28.61% increase from the previous year's $302.077M.

May 08, 2024 | 8:46 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
P3 Health Partners reported a mixed Q1 2024 earnings result with a miss on EPS but a beat on sales, showing significant year-over-year growth.
The miss on EPS may concern some investors, potentially putting downward pressure on the stock. However, the significant beat on sales and year-over-year growth could offset concerns and signal underlying strength in the company's operations. The mixed results present a neutral short-term outlook as investors weigh the EPS miss against the sales beat.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100